REGENXBIO INC. (RGNX)
REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
REGENXBIO Completes Dosing in Confirmatory Study of RGX-202, Marking Completion of Registrational Development Program and Supporting Planned BLA Submission in Q3 2026
VENU Hosts Intimate FireSuite Investor Event in McKinney, Texas Featuring Three-Time Super Bowl Champion and VENU Shareholder Troy Aikman
CalciMedica Announces Private Placement Financing for Up to Approximately $49 Million to Advance Pulmonary Hypertension Program
Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762
Amendment to the registration rights agreement between the company and Chroma and Camtek, details
Palmer Square Capital BDC Inc. Announces Second Quarter 2026 Supplemental Dividend of $0.03
Coppernico Metals Announces the Voting Results of its 2026 Annual General Meeting
Garmin Ltd. schedules second quarter 2026 earnings call
Global Retailer JD Sports Fashion plc Begins Trading on OTCQX Best Market
Best Buy introduces RGB LED TVs to stores nationwide, ushering new era of home theater